Litcius/Paper detail

Mebhydrolin ameliorates glucose homeostasis in type 2 diabetic mice by functioning as a selective FXR antagonist

Tong Zhao, Jie Wang, Anxu He, Shan Wang, Yidi Chen, Jian Lu, Jianlu Lv, Shiliang Li, Jiaying Wang, Minyi Qian, Honglin Li, Xu Shen

2021Metabolism37 citationsDOI

Topics & Concepts

AntagonistGlucose homeostasisHomeostasisInternal medicineEndocrinologyType 2 diabetesMedicineChemistryPharmacologyDiabetes mellitusReceptorInsulin resistanceDrug Transport and Resistance MechanismsDiabetes Treatment and ManagementEstrogen and related hormone effects
Mebhydrolin ameliorates glucose homeostasis in type 2 diabetic mice by functioning as a selective FXR antagonist | Litcius